CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Growth in home-based healthcare market
3.5.1.2. Increase in adoption of injectable drugs
3.5.1.3. Rise in incidence rate of chronic disease
3.5.1.4. Benefits of using prefilled syringes over conventional vials
3.5.1.5. Technological advancement
3.5.2. Restraints
3.5.2.1. Stringent government regulations
3.5.2.2. Availability of alternate drug-delivery methods
3.5.2.3. Product recalls
3.5.3. Opportunities
3.5.3.1. Rise in demand for biologics and biosimilars
3.5.3.2. Increase in demand for injectable drugs in prefilled forms
CHAPTER 4 PREFILLED SYRINGES MARKET, BY MATERIAL
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. GLASS-BASED PREFILLED SYRINGES
4.2.1. Market size and forecast
4.3. PLASTIC-BASED PREFILLED SYRINGES
4.3.1. Market size and forecast
CHAPTER 5 PREFILLED SYRINGES MARKET, BY DESIGN
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. SINGLE-CHAMBER PREFILLED SYRINGES
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.3. DUAL-CHAMBER PREFILLED SYRINGES
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.4. CUSTOMIZED PREFILLED SYRINGES
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
CHAPTER 6 PREFILLED SYRINGES MARKET, BY THERAPEUTICS
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. LARGE MOLECULES
6.2.1. Market size and forecast
6.3. SMALL MOLECULES
6.3.1. Market size and forecast
CHAPTER 7 PREFILLED SYRINGES MARKET, BY APPLICATION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. ANAPHYLAXIS
7.2.1. Market size and forecast
7.3. RHEUMATOID ARTHRITIS
7.3.1. Market size and forecast
7.4. DIABETES
7.4.1. Market size and forecast
7.5. OTHERS APPLICATIONS
7.5.1. Market size and forecast
CHAPTER 8 PREFILLED SYRINGES MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. India market size and forecast
8.4.3.2. Japan market size and forecast
8.4.3.3. China market size and forecast
8.4.3.4. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. South Africa market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. BECTON, DICKINSON AND COMPANY
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments
9.2. MEDTRONIC PLC
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. GERRESHEIMER AG
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. TERUMO MEDICAL CORPORATION
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. WEST PHARMACEUTICAL SERVICES, INC.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. NIPRO CORPORATION
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments
9.7. UNILIFE CORPORATION
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments
9.8. VETTER PHARMA INTERNATIONAL GMBH
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. BAXTER INTERNATIONAL
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. ABBOTT LABORATORIES
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments